Drugs / CD19-STAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03953599 | Jul 2019 → Jul 2021 | B-cell neoplasm | Hebei Yanda Ludaopei Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD19-STAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03953599 ↗ |
| Modality | Cell therapy | “CD19-STAR-T cell therapy” NCT03953599 ↗ |